yes agreed, its market sensitive and therefore needed to go to market
but I think you are missing the point
because it was only once they signed off on the agreement that it needed to go to market
they could just as easily held off on actually signing the document for a a few weeks while it was further reviewed by legal / regulatory / board etc and so have it coincide with the AGM, if they wanted to and if they need a big announcement for the AGM
so my point still stands... they simply processed the deal as it came through, because they didn't need it to dress up the AGM
Ann: Taiwan FDA Approval for PolyNovo, page-20
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
-0.035(1.43%) |
Mkt cap ! $1.685B | |||
| Open | High | Low | Value | Volume |
| $2.43 | $2.43 | $2.40 | $606.7K | 250.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 26272 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 15110 | 26 |
View Market Depth
| Last trade - 12.41pm 29/08/2024 (20 minute delay) ? |
| PNV (ASX) Chart |